Biochemical markers of bone formation [alkaline phosphatase, osteocalcin, a
nd carboxyterminal propeptide of type I procollagen (PICP)] and bone resorp
tion [cross-linked carboxyterminal telopeptide of type I collagen (ICTP) an
d cross-linked N-telopeptides of type I collagen (NTX)] were measured in 14
children aged 8.5-10.5 mo with vitamin D deficiency rickets before and lon
gitudinally during vitamin D treatment (3000-4000 IU/daily). Forty-four hea
lthy children aged 8-10.5 mo were enrolled as sex- and age-matched controls
. Before treatment, serum levels of alkaline phosphatase, PICP, and ICTP, a
nd urinary excretion values of NTX were significantly higher, and serum ost
eocalcin levels significantly lower than controls (31.4 +/- 3.5 mu kat/L an
d 9.8 +/- 2.9 mu kat/L, p < 0.001; 1025 +/- 89 mu g/L and 952 +/- 97.4 mu g
/L, p < 0.02; 15.6 +/- 2.6 mu g/L and 14.2 +/- 1.3 mu g/L, p < 0.01; 370.7
+/- 109.4 nmol BCE and 201.8 +/- 69.2 nmol BCE, p < 0.001; 17.6 +/- 9.1 mu
g/L and 22.5 +/- 7.6 mu g/L, p < 0.05, respectively). During treatment, ser
um alkaline phosphatase levels progressively declined in association with t
he radiographic healing of the skeletal lesions. Serum levels of osteocalci
n, PICP, and ICTP, and urinary excretion values of NTX showed a transient b
ut significant (p < 0.05 to p < 0.001) increase in comparison with baseline
values during the first 2-4 wk of treatment, and decreased slowly thereaft
er. They were within the mean +/- 2 SD of controls before the recovery of t
he skeletal lesions.
Conclusions: These findings suggest that children with vitamin D deficiency
rickets have increased bone turnover before and during the first weeks of
treatment. Alkaline phosphatase is a more reliable marker than osteocalcin,
PICP, ICTP and NTX for diagnosing and monitoring these patients.